GENETIC CHARACTERISTICS OF STAPHYLOCOCCUS AUREUS № 6 STRAIN - PRODUCER OF SECRETED PROTEIN-CONTAINING COMPOUNDS POSSESSING PROTECTIVE PROPERTIES
- Authors: Borisova O.Y.1, Gruber I.M2, Egorova N.B2, Ignatova O.M2, Astashkina E.A2
-
Affiliations:
- Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology
- Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
- Issue: Vol 91, No 6 (2014)
- Pages: 43-47
- Section: Articles
- Submitted: 09.06.2023
- Published: 15.12.2014
- URL: https://microbiol.crie.ru/jour/article/view/14000
- ID: 14000
Cite item
Full Text
Abstract
Aim. Genotype characteristics of Staphylococcus aureus № 6 strain that is a producer of a protective protein complex. Materials and methods. Features of structure of 9 genes, that code synthesis of pathogenicity factors, of S. aureus - spa, coa, seа, seв, se^ pvl, tst-h, mecA and scc-mecA, that are responsible for synthesis of protein A, coagulase, enterotoxins A, B and C, Panton-Valentine toxin (PVL), heat shock syndrome protein, resistance to methicillin and staphylococci chromosomal cassette, respectively, were studied by amplification in PCR of the respective gene fragments with subsequent conduction of direct sequencing. Results. The S. aureus № 6 strain under study possesses pvl gene fragments, as well as spa and coa genes, detected in all the studied strains, that belong to t12507 and ЕMRSA-16 types, respectively. Sea, seb, sec genes responsible for the synthesis of enterotoxins A, B and C were not detected in it, tst-h, mecA and scc-mecA gene fragments were not present. Conclusion. The detection of pvl gene fragment in the strain under study, on the one hand, and protective properties of the secreted protein-containing compound, on the other hand, give evidence in favor of the necessity of further analysis of extracellular proteome of S. aureus № 6.
About the authors
O. Yu Borisova
Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology
I. M Gruber
Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
N. B Egorova
Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
O. M Ignatova
Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
E. A Astashkina
Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia
References
- Гостев В.В., Гончаров А.Е., Грачева М.А., Сидоренко С.В. Распространение генов комплекса Immune evasion cluster и других факторов вирулентности у Staphylococcus aureus. Клин.микробиол. антимикроб. химиотер. 2013, 4: 270-278.
- Грубер И.М., Доненко Ф.В., Игнатова О.М. и др. Анализ внеклеточного протеома Staphylococcus aureus № 6 в конце фазы экспоненциального роста. Журн. микробиол. 2013, 3: 3-12.
- Грубер И.М., Егорова Н.Б., Курбатова Е.А., Михайлова Н.А. Стратегия разработки противостафилококковых иммунопрофилактических и иммунотерапевтических препаратов. Эпидемиология и инфекционные болезни. Актуальные вопросы. 2013, 4: 3138.
- Дмитренко О.А. Молекулярно-генетические аспекты эпидемиологии внутрибольничных инфекций, вызванных представителями вида Staphylococcus aureus, устойчивыми к метициллину/оксациллину. Автореф. дис. д-ра. мед. наук. М., 2008.
- Дмитренко О.А. Род Staphylococcus. В: Руководство по медицинской микробиологии. Оппортунистические инфекции: возбудители и этиологическая диагностика. Под.ред. Н.Н. Костюковой. М., БИНОМ, 2013.
- Дмитренко О.А., Матвеев С.М., Анкирская А.С., Любасовская Л.А., Ковалишена О.В., Широкова И.Ю., Попов Д.А. Структурный полиморфизм стафилококковых хромосомных кассет mec (SCCmec) у представителей вида Staphylococcus epidermidis, выделенных в стационарах Российской Федерации. Эпидемиология и вакцинопрофилактика. 2013, 4 (71): 21-29.
- David M.Z., Daum R.S. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev. 2010, 23 (3): 616-687.
- McCarthy A. J., Lindsay J. A.Staphylococcus aureus innate immune evasion is lineage-specific: A bioinfomatics study. Infect. Genet. Evol. 2013, 19: 7-14.
- Otto M. Novel targeted immunotherapy approaches for staphylococcal infection. Expert Opin. Biol. Ther. 2010, 10 (7): 1049-1059.
- vanWamel W.J., Rooijakkers S.H., Ruyken M. et al. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. J. Bacteriol. 2006, 188 (4): 13101315.
- Watkins R.R., David M.Z., Salata R.A. Current concepts on the virulence mechanisms of meticillin-resistant Staphylococcus aureus. J. Med. Microbiol. 2012, 61: 1179-1193.